Lyophilized (freeze-dried) powder remains stable for extended periods when kept cold and protected from light
It replicates a 15-amino-acid fragment of the BPC protein naturally present in human gastric juice
There is no direct evidence that the combined injection meaningfully increases fat loss on its own
This guide examines theoretical cagrilintide dosage protocols when combined with tirzepatide, potential synergies and risks, conservative vs aggressive dosing strategies, comparing this combination to proven alternatives (CagriSema, tirzepatide monotherapy), who might consider this experimental approach, and safer evidence-based options that deliver comparable results
The formulation includes 10 mg of BPC-157, 50 mg of GHK-CU, and 10 mg of TB500 , provided as a lyophilized powder for controlled laboratory use